• Global News
  • Press Releases
  • Publications
  • Ambrotose® Complex Study Conducted By Scientists From Flinders University And The University Of South Australia Is Published

     Dr. Talitha Best
    Dr. Talitha Best

    In a 12-week, randomized, double-blind, placebo-controlled trial, healthy middle-aged adults who took Ambrotose® complex performed significantly better on memory tasks and were overall more positive in their mood*(1). Dr. Talitha Best and Dr. Eva Kemps (School of Psychology, Flinders University, Adelaide, Australia) and Dr. Janet Bryan (School of Psychology, University of South Australia, Adelaide) published their findings in the January 2010 issue of Developmental Neuropsychology, a prestigious, peer-reviewed scientific journal. Study was at least partially funded by Mannatech.

    1. Best T, Kemps E, Bryan J. Saccharide effects on cognition and well-being in middle-aged adults: A randomized controlled trial. Developmental Neuropsychology 2010; 35(1): 66 -80.
    Dec 31, 2009 at 3:04 pm | Publications

    BounceBack™ Capsules Study Conducted By Scientists From Medicus Research LLC And The University Of California, Los Angeles (UCLA) Is Published

    jun-5-2009BounceBack™ capsules were able to significantly reduce standardized measures of pain and tenderness at several post-eccentric exercise time points in comparison to placebo (1). Jay Udani, MD (Medicus Research LLC, Northridge, California and UCLA Geffen School of Medicine), and Drs. Betsy Singh and Vijay Singh (Medicus Research LLC) published the randomized, double-blind, placebo-controlled crossover trial in the Journal of the International Society of Sports Nutrition.Study was at least partially funded by Mannatech.

      Udani J, Singh B, Singh V (2009) BounceBack capsules for reduction of DOMS after eccentric exercise: a randomized, double-blind, placebo-controlled, crossover pilot study. J Int Soc Sports Nutr 6(14):1-6.
      Download Research PDF
      Note: This article can also be accessed from PubMed.

    Jun 5, 2009 at 2:45 pm | Publications

    Scientists from Howard University publish Ambrotose® complex study in the journal Perceptual & Motor Skills

    Howard University
    Howard University
    Drs. Atiya N. Stancil and Leslie H. Hicks, both of Howard University in Washington, D.C., published a randomized, double-blind, placebo-controlled study investigating the impact of Ambrotose complex on the brain function of 62 healthy young adults. The study showed that a single, one-tablespoon serving of Ambrotose complex significantly improved visual discrimination and working memory. Mannatech, Incorporated donated the product used in this study, which was funded by Kraft Foods, Inc. (1).

    Previous double-blind, placebo-controlled clinical trials have demonstrated that ingestion of Ambrotose complex can enhance brain waves associated with attention or alertness (2), enhance concentration and improve mental reaction time (3), and improve memory (4).

    1. Stancil AN, Hicks LH. Glyconutrients and perception, cognition, and memory. Perceptual Mot Skills 2009;10:259-70.
    2. Wang C, Szabo JS, Dykman RA. Effects of a carbohydrate supplement upon resting brain activity. Integr Physiol Behav Sci 2004;39:126-38.
    3. Wang C, Pivik RT, Dykman RA. Effects of a glyconutritional supplement on brain potentials associated with language processing. Federation Proceedings: Experimental Biology Meeting, New Orleans, Louisiana, April 20-24. 2002;1-4 (abstr).
    4. Best T, Kemps E, Bryan J. The impact of saccharide supplementation on cognition and mood in middle-aged adults. Presented at the 36th Annual International Neuropsychological Society Meeting, February 6-9, 2008, Waikoloa, Hawaii 2008.
    Apr 16, 2009 at 2:39 pm | Publications

    Mannatech’s OsoLean™ powder study published in the Open Nutraceuticals Journal

    Mannatech scientists (left to right), Jane Anderson, Dr. Robert A. Sinnott, Dr. Erika Nelson and Dr. Rolando L. Maddela discuss the OsoLean™ powder publication.
    Mannatech scientists (left to right), Jane Anderson, Dr. Robert A. Sinnott, Dr. Erika Nelson and Dr. Rolando L. Maddela discuss the OsoLean™ powder publication.

    A clinical study of OsoLean powder funded by Mannatech was published this week in the Open Nutraceuticals Journal. This preliminary, open-label, 8-week study of 112 overweight adults demonstrated that daily intake of OsoLean powder appeared to reduce appetite, support weight loss and reduce waist circumference. The study was conducted by Mannatech scientists in collaboration with researchers at the University of North Texas Health Science Center in Fort Worth, TX. In a related 12-week double-blind, placebo-controlled study published in 2008, consumption of the same peptide blend in OsoLean powder in a flavored, sweetened beverage, in conjunction with a 500-calorie reduced diet, helped to enhance fat loss and retain lean muscle mass when compared to control subjects consuming a placebo in addition to dieting. To read more about Mannatech’s science, including these studies, go to the Publications section of this site.

    Sinnott RA, Maddela RL, Nelson ED, Bae S, Singh KP, Anderson JA. The modifying effects of a calcium-rich whey protein supplement (OsoLean™ Powder) on weight loss and waist circumference in overweight subjects: a preliminary study. Open Nutraceuticals J 2009; 2:36-41.

    Frestedt JL, Zenk JL, Kuskowski MA, Ward LS, Bastian ED. A whey-protein supplement increases fat loss and spares lean muscle in obese subjects: a randomized human clinical study. Nutr Metab (Lond) 2008; 5:8.

    Mar 16, 2009 at 2:33 pm | Publications